Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001468316-26-000008

Director sold 10,079 shares at $8.36 ($84,260)

  • Director acquired 15,598 shares (option exercise)
  • Director acquired 5,208 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Raykov Rosty · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Exercise or conversion : show line 1 in the form 10b5-1 +15,598 $2.45 $38,215 114,075 D
2026-03-02 Sale : show line 2 in the form 10b5-1 −10,079 $8.36 $84,260 103,996 D
2026-02-28 Grant or award : show line 3 in the form 10b5-1 +5,208 109,204 D
Open-market sales · 10,079 sh · avg $8.36 · $84,260

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Exercise or conversion : show line 4 in the form 10b5-1 Stock Options −15,598 $2.45 $38,215 1,587,390 D
Loading xslF345X05/form4-03032026_040301.xml…